HUTCHMED (China) Balance Sheet Health
Financial Health criteria checks 4/6
HUTCHMED (China) has a total shareholder equity of $752.0M and total debt of $82.1M, which brings its debt-to-equity ratio to 10.9%. Its total assets and total liabilities are $1.3B and $508.9M respectively.
Key information
10.9%
Debt to equity ratio
US$82.10m
Debt
| Interest coverage ratio | n/a |
| Cash | US$803.51m |
| Equity | US$752.02m |
| Total liabilities | US$508.85m |
| Total assets | US$1.26b |
Recent financial health updates
No updates
Recent updates
Hutchmed Growing Sales By 64% In H1 2024
Aug 09Hutchmed Is Turning Profitable
Mar 20Hutchmed begins dosing in phase 2/3 trial of sovleplenib for red blood cell disorder
Oct 10Hutchmed, Inmagene begin dosing in phase 1 trial of potential autoimmune disease drug IMG-004
Aug 09Hutchmed begins dosing in mid-stage study of tazemetostat in blood cancer subtype
Aug 01Hutchmed begins dosing in early-stage study of cancer drug HMPL-A83
Jul 15Hutchmed, Inmagene begin dosing in early-stage study of IMG-007 for eczema
Jul 06Hutchmed Roils Markets With Changing Of Its Guard, U.S. Delisting Threat
Mar 11Financial Position Analysis
Short Term Liabilities: HCM's short term assets ($1.0B) exceed its short term liabilities ($373.3M).
Long Term Liabilities: HCM's short term assets ($1.0B) exceed its long term liabilities ($135.6M).
Debt to Equity History and Analysis
Debt Level: HCM has more cash than its total debt.
Reducing Debt: HCM's debt to equity ratio has increased from 0.2% to 10.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HCM has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if HCM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.